肺炎球菌疫苗的进展：13价肺炎球菌结合疫苗在欧洲获得市场授权。 - Suppr

Suppr

超能文献

Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe.

作者信息

Reinert Ralf R, Paradiso Peter, Fritzell Bernard

出版信息

Expert Rev Vaccines. 2010 Mar;9(3):229-36. doi: 10.1586/erv.10.6.

DOI:10.1586/erv.10.6

PMID:20218848

Abstract

摘要

相似文献

Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe.

Expert Rev Vaccines. 2010 Mar;9(3):229-36. doi: 10.1586/erv.10.6.

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.

Expert Rev Vaccines. 2009 Oct;8(10):1351-64. doi: 10.1586/erv.09.78.

7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.

Prescrire Int. 2002 Feb;11(57):7-10.

Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.

MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):258-61.

Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.

Prescrire Int. 2006 Dec;15(86):227-33.

Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).

Vaccine. 2007 Mar 8;25(12):2194-212. doi: 10.1016/j.vaccine.2006.11.032. Epub 2006 Dec 4.

Clinical characteristics of a novel 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine candidate (PHiD-CV). Introduction.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S63-5. doi: 10.1097/INF.0b013e318199f5f2.

[Value of pneumococcal vaccination in infants and young children].

Klin Padiatr. 2001 May-Jun;213(3):109-13. doi: 10.1055/s-2001-15860.

The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S89-96. doi: 10.1097/INF.0b013e318199f901.

Issues in pneumococcal disease and pneumococcal conjugate vaccines: highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9-13, 2009.

Vaccine. 2009 Nov 23;27(50):7133-7. doi: 10.1016/j.vaccine.2009.08.084.

引用本文的文献

Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.

Open Forum Infect Dis. 2023 Aug 11;10(8):ofad417. doi: 10.1093/ofid/ofad417. eCollection 2023 Aug.

Incidence of non-invasive all-cause pneumonia in children in the United States before and after the introduction of pneumococcal conjugate vaccines: a retrospective claims database analysis.

Pneumonia (Nathan). 2023 Apr 5;15(1):8. doi: 10.1186/s41479-023-00109-5.

Strengths and weaknesses of pneumococcal conjugate vaccines.

Glycoconj J. 2023 Apr;40(2):135-148. doi: 10.1007/s10719-023-10100-3. Epub 2023 Jan 18.

Serotypes and Vaccine Coverage of Colonization in the Nasopharynx of Thai Children in Congested Areas in Chiang Mai.

Pathogens. 2020 Nov 26;9(12):988. doi: 10.3390/pathogens9120988.

Molecular serotyping and genotyping of penicillin non-susceptible pneumococci: the introduction of new sequence types, Tehran, Iran.

New Microbes New Infect. 2019 Sep 6;32:100597. doi: 10.1016/j.nmni.2019.100597. eCollection 2019 Nov.

Multicomponent polysaccharide-protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates.

Chem Sci. 2018 Jan 19;9(9):2581-2588. doi: 10.1039/c7sc05467j. eCollection 2018 Mar 7.

Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Serotype 1.

ACS Cent Sci. 2018 Mar 28;4(3):357-361. doi: 10.1021/acscentsci.7b00504. Epub 2018 Mar 14.

Capsule Prolongs Survival of Streptococcus pneumoniae during Starvation.

Infect Immun. 2018 Feb 20;86(3). doi: 10.1128/IAI.00802-17. Print 2018 Mar.

Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for .

Synth Syst Biotechnol. 2017 Jan 20;2(1):49-58. doi: 10.1016/j.synbio.2016.12.002. eCollection 2017 Mar.

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):19-31. doi: 10.1007/s10096-014-2208-6. Epub 2014 Aug 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验